Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Parmjit S Jat
Affiliation
UCL Institute of Prion Diseases
ORCID
Career Start Year
1981
Papers
100
H Index
43
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36535427
Prion Propagation is Dependent on Key Amino Acids in Charge Cluster 2 within the Prion Protein.
J Mol Biol
2023
37069149
Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.
Signal Transduct Target Ther
2023
35158800
Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases.
Cancers (Basel)
2022
35680944
A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody.
Sci Rep
2022
34728711
Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence.
Sci Rep
2021
33855023
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype.
Front Cell Dev Biol
2021
33610557
Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.
J Mol Biol
2021
32949544
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.
Lancet Neurol
2020
32944514
Isolation, purification, and conditional immortalization of murine glomerular endothelial cells of microvascular phenotype.
MethodsX
2020
32900920
Highly infectious prions are not directly neurotoxic.
Proc Natl Acad Sci U S A
2020
31519924
Generation of c-MycER<sup>TAM</sup>-transduced human late-adherent olfactory mucosa cells for potential regenerative applications.
Sci Rep
2019
27213811
Establishment of a Conditionally Immortalized Wilms Tumor Cell Line with a Homozygous WT1 Deletion within a Heterozygous 11p13 Deletion and UPD Limited to 11p15.
PLoS One
2016
26619948
Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.
Int J Cancer
2016
25311251
Identification of clinical target areas in the brainstem of prion-infected mice.
Neuropathol Appl Neurobiol
2015
26631378
A systematic investigation of production of synthetic prions from recombinant prion protein.
Open Biol
2015
26172396
Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
J Pathol
2015
24270410
The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300.
Cell Death Differ
2014
25557529
Tumour suppressors and cellular senescence.
IUBMB Life
2014
25255445
Regulation of p53 and Rb links the alternative NF-κB pathway to EZH2 expression and cell senescence.
PLoS Genet
2014
25278290
Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol
2014
24981831
Cellular senescence and aging: the role of B-MYB.
Aging Cell
2014
24833721
In vitro screen of prion disease susceptibility genes using the scrapie cell assay.
Hum Mol Genet
2014
24843046
Identification of a gene regulatory network associated with prion replication.
EMBO J
2014
23572577
Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients.
Proc Natl Acad Sci U S A
2013
24043947
Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence.
Onco Targets Ther
2013
23625514
Effects of CT-Xp gene knock down in melanoma cell lines.
Oncotarget
2013
23615505
The expression of podocyte-specific proteins in parietal epithelial cells is regulated by protein degradation.
Kidney Int
2013
21242976
Activation of nuclear factor-kappa B signalling promotes cellular senescence.
Oncogene
2011
21990145
Deciphering the role of nuclear factor-κB in cellular senescence.
Aging (Albany NY)
2011
21740549
An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence.
BMC Genomics
2011
21505437
Rapid cell-surface prion protein conversion revealed using a novel cell system.
Nat Commun
2011
19955187
Conditionally immortalized human podocyte cell lines established from urine.
Am J Physiol Renal Physiol
2010
21137025
Proteome profiling of immortalization-to-senescence transition of human breast epithelial cells identified MAP2K3 as a senescence-promoting protein which is downregulated in human breast cancer.
Proteomics Clin Appl
2010
20668098
Cell-cell contact regulates gene expression in CDK4-transformed mouse podocytes.
Am J Physiol Renal Physiol
2010
20642837
Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.
Breast Cancer Res
2010
18922873
Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding.
J Virol
2009
19615061
Identification of differentially expressed sense and antisense transcript pairs in breast epithelial tissues.
BMC Genomics
2009
19737964
Decreased poly(ADP-ribosyl)ation of CTCF, a transcription factor, is associated with breast cancer phenotype and cell proliferation.
Clin Cancer Res
2009
18188180
A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding.
EMBO Rep
2008
17488820
Surveillance mechanism linking Bub1 loss to the p53 pathway.
Proc Natl Acad Sci U S A
2007
17600495
Preparation of monoclonal antibodies against the spindle checkpoint kinase Bub1.
Hybridoma (Larchmt)
2007
17283147
Ability to acquire drug resistance arises early during the tumorigenesis process.
Cancer Res
2007
16234270
Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway.
Am J Physiol Endocrinol Metab
2006
17005159
Retrovirus-mediated conditional immortalization and analysis of established cell lines of osteoclast precursor cells.
Biochem Biophys Res Commun
2006
17085477
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases.
Nucleic Acids Res
2006
17014703
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
Breast Cancer Res
2006
15574883
Transcriptional networks and cellular senescence in human mammary fibroblasts.
Mol Biol Cell
2005
14732683
Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1.
Proc Natl Acad Sci U S A
2004
15572682
Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival.
Mol Cell Biol
2004
15188452
Order of genetic events is critical determinant of aberrations in chromosome count and structure.
Genes Chromosomes Cancer
2004
1 - 50 of 100
Column Actions
Search
Recommended Authors
Vera Gorbunova
University of Rochester
Career Start Year
1997
Number of shared co-authors
0
Christian Beaus??jour
CHU Sainte-Justine Research Center
Career Start Year
1996
Number of shared co-authors
0
William Clark
Cancer Research UK Beatson Institute
Career Start Year
1993
Number of shared co-authors
0
Stephen Chung
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
0
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Career Start Year
1993
Number of shared co-authors
0
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year
1991
Number of shared co-authors
0
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1991
Number of shared co-authors
0
Andrew Wakeham
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year
1989
Number of shared co-authors
0
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year
1987
Number of shared co-authors
0
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year
1987
Number of shared co-authors
1
Claudio Schneider
Laboratorio Nazionale-Consorzio Interuniversitario per le Biotecnologie
Career Start Year
1987
Number of shared co-authors
1
Satyajit Ray
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1986
Number of shared co-authors
0
Siu-Pok Yee
University of Connecticut Health Center
Career Start Year
1981
Number of shared co-authors
0
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1981
Number of shared co-authors
2
David J Adams
Wellcome Sanger Institute
Career Start Year
1980
Number of shared co-authors
8
David M Thomas
Garvan Institute of Medical Research
Career Start Year
1980
Number of shared co-authors
5
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Career Start Year
1979
Number of shared co-authors
0
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1978
Number of shared co-authors
0
Martine F Roussel
St. Jude Children's Research Hospital
Career Start Year
1977
Number of shared co-authors
0
Lawrence A Donehower
Baylor College of Medicine
Career Start Year
1975
Number of shared co-authors
3
Bruce J Aronow
Cincinnati Children's Hospital Medical Center
Career Start Year
1975
Number of shared co-authors
2
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year
1975
Number of shared co-authors
1
Hartmut Land
University of Rochester Medical Center, Wilmot Cancer Institute
Career Start Year
1974
Number of shared co-authors
5
Owen N Witte
University of California los angeles
Career Start Year
1972
Number of shared co-authors
3
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1970
Number of shared co-authors
2
Charles J Sherr
St. Jude Children's Research Hospital
Career Start Year
1968
Number of shared co-authors
0
Tony Hunter
Salk Institute for Biological Studies
Career Start Year
1968
Number of shared co-authors
0
Arnold J Levine
Simons Center for Systems Biology, Institute for Advanced Study
Career Start Year
1967
Number of shared co-authors
1
J. Carl Barrett
Oncology R&D
Career Start Year
1966
Number of shared co-authors
2
Norman E Sharpless
National Cancer Institute
Career Start Year
1945
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Paris Ataliotis
Molecular and Clinical Sciences Research Institute, University of London
Co-authored papers
6
Sunil R Lakhani
University of Queensland
Co-authored papers
5
Andrew K Groves
Baylor College of Medicine
Co-authored papers
5
Mark Noble
University of Rochester Medical Center
Co-authored papers
5
Alan Mackay
Co-authored papers
4
Sebastian Brandner
UCL Queen Square Institute of Neurology
Co-authored papers
4
Otavia L Caballero
Ludwig Institute for Cancer Research Ltd.
Co-authored papers
3
Andrew J G Simpson
University of Hull
Co-authored papers
3
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers
3
Alan Entwistle
The Ludwig Institute for Cancer Research
Co-authored papers
3
Jeffrey B Kopp
National Institutes of Health, National Institute of Diabetes
Co-authored papers
2
Jean J Zhao
Co-authored papers
2
Leonard Da Silva
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Co-authored papers
2
K Bevan
Co-authored papers
2
Susan C Barnett
University of Glasgow, University Place
Co-authored papers
2
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers
2
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Co-authored papers
2
Damian R Wren
Frimley Health NHS Foundation Trust
Co-authored papers
1
Steven M Dubinett
David Geffen School of Medicine at university of california los angeles
Co-authored papers
1
Sean M Grimmond
The University of Melbourne
Co-authored papers
1
Chris Jones
Co-authored papers
1
Matthew J Smalley
European Cancer Stem Cell Research Institute, Cardiff University
Co-authored papers
1
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers
1
Gaetano Zafarana
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
1
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers
1
Philippe Amouyel
Co-authored papers
1
Robert L Strausberg
Ludwig Institute for Cancer Research
Co-authored papers
1
Carmen de Torres
Co-authored papers
1
Constance L Cepko
Howard Hughes Medical Institute, Harvard Medical School
Co-authored papers
1
Federico Martin??n-Torres
Hospital Clinico Universitario de Santiago de Compostela
Co-authored papers
1
1 - 30